UNIVERSITY AT BUFFALO
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1846-01-01
- Employees
- 5.2K
- Market Cap
- -
- Website
- https://www.buffalo.edu/
The Protective Effect of Friendship on Peer Rejection in Overweight and Normal Weight Youth
- First Posted Date
- 2011-03-29
- Last Posted Date
- 2011-09-30
- Lead Sponsor
- University at Buffalo
- Target Recruit Count
- 104
- Registration Number
- NCT01324661
- Locations
- 🇺🇸
University at Buffalo Division of Behavioral Medicine, Buffalo, New York, United States
Liraglutide as Additional Treatment in Patients With Type 1 Diabetes Mellitus
Completed
- Conditions
- First Posted Date
- 2011-02-18
- Last Posted Date
- 2017-02-09
- Lead Sponsor
- University at Buffalo
- Target Recruit Count
- 30
- Registration Number
- NCT01299012
Vancomycin-Associated Nephrotoxicity
Completed
- Conditions
- First Posted Date
- 2010-10-07
- Last Posted Date
- 2022-10-03
- Lead Sponsor
- University at Buffalo
- Target Recruit Count
- 398
- Registration Number
- NCT01216540
- Locations
- 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States
Effect of Pioglitazone on Oxidative Load, Inflammatory End-Points and Vascular Reactivity in Obese Non-Diabetic Patients: A Dose Ranging Study
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-07-13
- Last Posted Date
- 2022-01-27
- Lead Sponsor
- University at Buffalo
- Target Recruit Count
- 24
- Registration Number
- NCT01161394
- Locations
- 🇺🇸
Millard Fillmore gates Hospital, Buffalo, New York, United States
Resveratrol in Type2 Diabetes and Obesity
Not Applicable
Terminated
- Conditions
- Interventions
- First Posted Date
- 2010-07-08
- Last Posted Date
- 2022-11-09
- Lead Sponsor
- University at Buffalo
- Target Recruit Count
- 15
- Registration Number
- NCT01158417
- Locations
- 🇺🇸
Jeanne Hejna, Williamsville, New York, United States
Exeantide in Type 2 Diabetes on Insulin
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-07-01
- Last Posted Date
- 2022-10-06
- Lead Sponsor
- University at Buffalo
- Target Recruit Count
- 24
- Registration Number
- NCT01154933
- Locations
- 🇺🇸
Millard Fillmore Gates Hospital, Buffalo, New York, United States
The Suppression of Toll Like Receptors by Insulin
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-06-28
- Last Posted Date
- 2024-01-05
- Lead Sponsor
- University at Buffalo
- Target Recruit Count
- 30
- Registration Number
- NCT01151605
- Locations
- 🇺🇸
Millard Fillmore Gates Hospital, Buffalo, New York, United States
Testosterone Replacement in Men With Diabetes and Obesity
- First Posted Date
- 2010-05-21
- Last Posted Date
- 2022-11-29
- Lead Sponsor
- University at Buffalo
- Target Recruit Count
- 137
- Registration Number
- NCT01127659
- Locations
- 🇺🇸
115 Flint Road, Williamsville, New York, United States
Effect of Adrenocorticotropin Injection With Weekly Interferon Beta in Patients With Relapsing Remitting Multiple Sclerosis (MS)
Phase 2
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2009-09-30
- Last Posted Date
- 2021-01-05
- Lead Sponsor
- University at Buffalo
- Registration Number
- NCT00986960
- Locations
- 🇺🇸
University at Buffalo, Buffalo General Hospital, Buffalo, New York, United States
Effect of Tysabri in Patients With Relapsing-Remitting Multiple Sclerosis: A Follow-up Magnetization Transfer Imaging (MTI) Study
- First Posted Date
- 2009-07-13
- Last Posted Date
- 2011-09-07
- Lead Sponsor
- University at Buffalo
- Target Recruit Count
- 85
- Registration Number
- NCT00937677
- Locations
- 🇺🇸
Jacobs Neurological Institute, Buffalo, New York, United States
© Copyright 2024. All Rights Reserved by MedPath